600518.SH
Kangmei Pharmaceutical Co., Ltd.
SSE · Healthcare · Medical - Pharmaceuticals · CN
CNY 1.34
−1.47%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenCNY 1.33
From 52W high−39.09%
Volume101.44M
Market capCNY 18.53B
P/E (TTM)1794.2x
P/S (TTM)3.7x
Div yield—
Key dataSep 18, 2026
Open
CNY 1.33
From 52W high
−39.09%
Volume
101.44M
Market cap
CNY 18.53B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
52.8x
P/E (TTM)
1794.2x
RSI (14)
45.3
MomentumView details →
1D Return
−1.47%
YTD Return
−29.32%
Similar companies
Latest newsMore news →
Kangmei Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 36.0348 million yuan, up 113.21% year-on-year, while revenue fell 11.13% to 2.29 billion yuan.27d agoKangmei Pharmaceutical's chairman Lai Zhijian resigned from his positions as chairman, director, and legal representative, and Ou Guoxiong was appointed to act as chairman and legal representative.31d ago